Shanghai Medicilon Inc
SSE:688202
Shanghai Medicilon Inc
Net Income (Common)
Shanghai Medicilon Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai Medicilon Inc
SSE:688202
|
Net Income (Common)
¥338.2m
|
CAGR 3-Years
72%
|
CAGR 5-Years
52%
|
CAGR 10-Years
N/A
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
¥2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
36%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Net Income (Common)
¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai Medicilon Inc's Net Income (Common)?
Net Income (Common)
338.2m
CNY
Based on the financial report for Dec 31, 2022, Shanghai Medicilon Inc's Net Income (Common) amounts to 338.2m CNY.
What is Shanghai Medicilon Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
52%
Over the last year, the Net Income (Common) growth was 20%. The average annual Net Income (Common) growth rates for Shanghai Medicilon Inc have been 72% over the past three years , 52% over the past five years .